Search Results
534 results
Your search is now limited to «Chemotherapy» expert search.
Targeted Oncology 01/21/2019 09:26
Because unlike traditional infusion oncology—where doctors, nurses and pharmacists directly oversee the process—oral chemotherapy requires the patients themselves to correctly administer the drug.
More from Targeted Oncology:
FeedNavigator 01/21/2019 08:39
Breast cancer has developed to become the leading type of cancer in females. For this study, 80 women were examined after chemotherapy for breast cancer and compared to 80 healthy age-matched women....
More from FeedNavigator:
NaturalNews.com 01/21/2019 05:56
Natural News) A study published in the American Journal of Physiology-Cell Physiology has found that chemotherapy can cause adverse effects on the skeletal muscle of patients undergoing treatment.
More from NaturalNews.com:
Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy. Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy, Published online: 21 January 2019; doi:10.1038/s41556-018-0267-0. Carlson et al.
More from Nature - Cell Biology:
Wearable Technologies 01/18/2019 07:45
Proteus Digital Health has launched a digital oncology treatment, which combines oral chemotherapy with its ingestible sensor, enabling oncologists to track treatment effectiveness and adherence in their cancer patients.
More from Wearable Technologies:
Cancer Therapy Advisor 01/17/2019 11:30
January 17, 2019 Immune checkpoint blockade combined with chemotherapy may sensitize “cold” tumors to immunotherapy and lead to enhanced responses.
More from Cancer Therapy Advisor:
Healio News 01/17/2019 09:10
Use of corticosteroids, certain dermatologic or mucosal conditions, and antibiotics all appeared to increase risk for chemotherapy-induced febrile neutropenia among a cohort of patients undergoing cancer treatment with myelosuppressive chemotherapy, according to study findings published in Journal of the National Comprehensive Cancer Network.
More from Healio News:
ClinicalTrials.gov 01/17/2019 08:50
Conditions : Recurrent B Acute Lymphoblastic Leukemia; Recurrent T Acute Lymphoblastic Leukemia; Refractory B Acute Lymphoblastic Leukemia; Refractory T Acute Lymphoblastic Leukemia Interventions : Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Dexamethasone; Drug: Methotrexate; Drug: Nelarabine; Drug: Pegaspargase; Drug: Prednisone; Biological: Rituximab; Drug: Venetoclax; Drug: Vincristine Sponsors : M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting.
More from ClinicalTrials.gov:
Lifeboat News: The Blog 01/17/2019 02:42
This review examined the potential roles of the phytochemicals from P. africana, an endangered, sub-Saharan Africa plant in the chemoprevention and chemotherapy of prostate cancer.
More from Lifeboat News: The Blog:
WN.com 01/17/2019 02:40
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Tecentriq® (atezolizumab) in combination with Abraxane® (albumin-bound paclitaxel; nab-paclitaxel) and carboplatin for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC) who do not ......
More from WN.com:
NASDAQ 01/17/2019 01:53
The FDA recently approved Tecentriq in combination with Avastin, paclitaxel and carboplatin (chemotherapy) for the initial treatment of people with metastatic non-squamous NSCLC with no EGFR or ALK genomic tumor aberrations.
More from NASDAQ:
The FDA recently approved Tecentriq in combination with Avastin, paclitaxel and carboplatin (chemotherapy) for the initial treatment of people with metastatic non-squamous NSCLC with no EGFR or ALK genomic tumor aberrations.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications